Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Zinc  COVID-19 treatment studies for Zinc  C19 studies: Zinc  Zinc   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent: 
0 0.5 1 1.5 2+ Severe case 18% Improvement Relative Risk c19zinc.com Citu et al. Zinc for COVID-19 Prophylaxis Favors zinc Favors control
Citu, 135 patient zinc prophylaxis study: 18% lower severe cases [p=1] https://c19p.org/citu
copied to clipboard
Calcium, Magnesium, and Zinc Supplementation during Pregnancy: The Additive Value of Micronutrients on Maternal Immune Response after SARS-CoV-2 Infection
Citu et al., Nutrients, doi:10.3390/nu14071445
30 Mar 2022    Source   PDF   Share   Tweet
Retrospective 448 pregnant women with COVID-19. Patients with calcium, zinc, and magnesium supplementation, or magnesium only, had a significantly higher titer of SARS-CoV-2 anti-RBD antibodies. There was no statistically significant difference in severe cases based on supplementation.
risk of severe case, 17.6% lower, RR 0.82, p = 1.00, treatment 2 of 74 (2.7%), control 2 of 61 (3.3%), NNT 174, Ca+Mg+Zn vs. Mg.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Citu et al., 30 Mar 2022, retrospective, Romania, peer-reviewed, survey, 14 authors, study period 14 April, 2020 - 14 February, 2022, this trial uses multiple treatments in the treatment arm (combined with calcium) - results of individual treatments may vary.
Contact: citu.ioan@umft.ro (corresponding author), citu.ioana@umft.ro, marganmm@gmail.com, crainamariuslucian@gmail.com, radu.neamtu@umft.ro, gorun.florin@umft.ro, oanabalan@hotmail.com, bogdanburlea@yahoo.com, felix.bratosin7@gmail.com, ovidiu.rosca@umft.ro, grigoras.mirela@umft.ro, amotoc@umft.ro, malita.daniel@umft.ro, dr.octavian.neagoe@gmail.com.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperZincAll
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit